Found: 14
Select item for more details and to access through your institution.
The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS).
- Published in:
- Dermatology & Therapy, 2018, v. 8, n. 1, p. 45, doi. 10.1007/s13555-017-0213-2
- By:
- Publication type:
- Article
The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health.
- Published in:
- Dermatology & Therapy, 2018, v. 8, n. 1, p. 33, doi. 10.1007/s13555-017-0212-3
- By:
- Publication type:
- Article
Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative Study.
- Published in:
- Dermatology & Therapy, 2017, v. 7, n. 4, p. 447, doi. 10.1007/s13555-017-0204-3
- By:
- Publication type:
- Article
Rectal Urgency Among Patients With Ulcerative Colitis or Crohn's Disease: Analyses from a Global Survey.
- Published in:
- Crohn's & Colitis 360, 2023, v. 5, n. 4, p. 1, doi. 10.1093/crocol/otad052
- By:
- Publication type:
- Article
Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adults.
- Published in:
- Journal of Patient-Reported Outcomes, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41687-022-00439-w
- By:
- Publication type:
- Article
伊赛珠单抗在中度至重度生殖器银屑病中的疗效和安全性.
- Published in:
- British Journal of Dermatology, 2018, v. 179, n. 4, p. e189, doi. 10.1111/bjd.17179
- By:
- Publication type:
- Article
Ixekizumab efficacy and safety in moderate‐to‐severe genital psoriasis.
- Published in:
- British Journal of Dermatology, 2018, v. 179, n. 4, p. e177, doi. 10.1111/bjd.17168
- By:
- Publication type:
- Article
Efficacy and safety of ixekizumab in a randomized, double‐blinded, placebo‐controlled phase IIIb study of patients with moderate‐to‐severe genital psoriasis.
- Published in:
- British Journal of Dermatology, 2018, v. 179, n. 4, p. 844, doi. 10.1111/bjd.16736
- By:
- Publication type:
- Article
Ixekizumab Results in Persistent Clinical Improvement in Moderateto-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial.
- Published in:
- Acta Dermato-Venereologica, 2020, v. 100, n. 1, p. 1, doi. 10.2340/00015555-3353
- By:
- Publication type:
- Article
Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 6, p. 1257, doi. 10.1111/jdv.16181
- By:
- Publication type:
- Article
Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate‐to‐severe psoriasis patients: 12‐week results from two phase III trials.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 1, p. 68, doi. 10.1111/jdv.14581
- By:
- Publication type:
- Article
Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trials.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 11, p. 1867, doi. 10.1111/jdv.14377
- By:
- Publication type:
- Article
Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 7, p. 2333, doi. 10.1007/s10620-024-08434-5
- By:
- Publication type:
- Article
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis.
- Published in:
- Crohn's & Colitis 360, 2022, v. 4, n. 3, p. 1, doi. 10.1093/crocol/otac016
- By:
- Publication type:
- Article